APA (7th ed.) Citation

Gkioka, A. I., Repousis, P., Papaioannou, P., Tryfou, T., Rougkala, N., Dimou, M., . . . Kyrtsonis, M. (2019). Prognostic value and clinical correlations of serum cereblon (CRBN) levels in multiple myeloma patients treated with Lenalidomide/Dexamethasone (RD). Clinical lymphoma, myeloma & leukemia, 19, e117. https://doi.org/10.1016/j.clml.2019.09.194

Chicago Style (17th ed.) Citation

Gkioka, Annita Ioanna, et al. "Prognostic Value and Clinical Correlations of Serum Cereblon (CRBN) Levels in Multiple Myeloma Patients Treated with Lenalidomide/Dexamethasone (RD)." Clinical Lymphoma, Myeloma & Leukemia 19 (2019): e117. https://doi.org/10.1016/j.clml.2019.09.194.

MLA (9th ed.) Citation

Gkioka, Annita Ioanna, et al. "Prognostic Value and Clinical Correlations of Serum Cereblon (CRBN) Levels in Multiple Myeloma Patients Treated with Lenalidomide/Dexamethasone (RD)." Clinical Lymphoma, Myeloma & Leukemia, vol. 19, 2019, p. e117, https://doi.org/10.1016/j.clml.2019.09.194.